logo
welcome
Mount Sinai Health System

Mount Sinai Health System

Mount Sinai Researchers Discover Novel Nanoparticles in Blood With Potential to Transform Cancer Diagnosis

Mount Sinai Health System
Summary
Nutrition label

89% Informative

Mount Sinai researchers have identified a new class of RNAs packed into tiny particles known as extracellular vesicles (EVs) The team found that these molecules undergo changes when cancer is present, suggesting their potential as biomarkers for detecting prostate cancer or as targets for therapy.

EV-UGRs may lead to a less invasive approach for diagnosing prostate cancer through simple liquid biopsies.

The paper is titled “ Extracellular Vesicles carry Transcriptional Dark Matter’ Revealing Tissue-Specific Information ” The work was supported by the National Institutes of Health ( NIH ) awards P20CA264076 and R21 AGO78848.

Hospitals within the System are consistently ranked by Newsweek ’s “ The World’s Best Smart Hospitals , Best in State Hospitals , World Best Hospitals and Best Specialty Hospitals ” and by U.S. News & World Report'sBest Hospitals ” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World ReportBest Hospitals” Honor Roll for 2024-2025 ..

VR Score

91

Informative language

94

Neutral language

21

Article tone

formal

Language

English

Language complexity

74

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

Affiliate links

no affiliate links